Girard Partners LTD. trimmed its holdings in Cardinal Health Inc (NYSE:CAH) by 48.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 10,574 shares of the company’s stock after selling 9,959 shares during the period. Girard Partners LTD.’s holdings in Cardinal Health were worth $516,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Signaturefd LLC acquired a new stake in Cardinal Health in the 1st quarter worth about $100,000. Optimum Investment Advisors acquired a new stake in Cardinal Health in the 1st quarter worth about $128,000. Mount Yale Investment Advisors LLC acquired a new stake in Cardinal Health in the 1st quarter worth about $136,000. Focused Wealth Management Inc acquired a new stake in Cardinal Health in the 1st quarter worth about $166,000. Finally, Archford Capital Strategies LLC acquired a new stake in Cardinal Health in the 1st quarter worth about $174,000. 89.98% of the stock is currently owned by hedge funds and other institutional investors.
Several equities analysts have recently weighed in on CAH shares. Zacks Investment Research lowered Cardinal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, April 17th. Leerink Swann raised Cardinal Health from a “market perform” rating to an “outperform” rating and set a $75.00 price objective on the stock in a research note on Tuesday, April 24th. Royal Bank of Canada set a $81.00 price objective on Cardinal Health and gave the company a “hold” rating in a research note on Tuesday, April 24th. ValuEngine lowered Cardinal Health from a “hold” rating to a “sell” rating in a research note on Wednesday, May 2nd. Finally, Jefferies Financial Group set a $55.00 price objective on Cardinal Health and gave the company a “hold” rating in a research note on Friday, May 4th. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company. Cardinal Health presently has a consensus rating of “Hold” and a consensus target price of $62.00.
Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Monday, August 6th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.08. The business had revenue of $35.35 billion for the quarter, compared to analyst estimates of $34.38 billion. Cardinal Health had a return on equity of 22.59% and a net margin of 0.19%. The company’s revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.31 EPS. sell-side analysts expect that Cardinal Health Inc will post 5.04 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, October 15th. Investors of record on Monday, October 1st will be issued a dividend of $0.4763 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.48. This represents a $1.91 annualized dividend and a dividend yield of 3.80%. The ex-dividend date of this dividend is Friday, September 28th. Cardinal Health’s dividend payout ratio (DPR) is presently 38.20%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as an integrated healthcare services and products company worldwide. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers.
Featured Article: What is the NASDAQ Stock Market?
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.